Trials / Completed
CompletedNCT02790684
A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, open-label, single-center, non-randomized study to assess the mass balance of a single oral dose of DS-8500a in healthy male subjects, 18 years (y) to 60 y of age, inclusive. The radiolabeled investigational medicinal product will be administered to 12 healthy male subjects in 2 cohorts of 6 subjects each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-8500a |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-06-06
- Last updated
- 2019-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02790684. Inclusion in this directory is not an endorsement.